Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Oliver Schinzinger, Ph.D.
Director Pharmaceutical Development
Corden Pharma, Germany
Poster(s):
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Monday, October 21, 2024
10:30 AM – 11:30 AM
MT